Pinned post
Very excited and proud to be apart of this trial!
NRG-GY035: A Randomized Phase III Trial of Carboplatin, Paclitaxel, Pembrolizumab vs Carboplatin, Paclitaxel, Bevacizumab vs Carboplatin, Paclitaxel, Pembrolizumab, Bevacizumab in Treatment of pMMR, TP53 Mutated Advanced or Recurrent #EndometrialCancer. @amandanfader @TabonesMTView quoted post on X